On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009. ....

  • No comment posted so far for this feed.
    Be the first one to post.
Please login to post comment!
Share insights, ideas, experience, opinion and earn for your published content!

News, articles, videos and other insightful content, curated from renowned sources across the globe.
About  |  Terms  |  Privacy Policy  |  Contact

© 2023 The Bulletin Box. All rights reserved.